• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

3I

Anonymous board for 3I
Replies
58
Views
32K
anonymous
Replies
3
Views
4K
anonymous
Replies
2
Views
3K
anonymous
Replies
0
Views
2K
anonymous
Replies
4
Views
4K
Anonymous
Replies
10
Views
7K
Anonymous
Replies
1
Views
4K
Anonymous
Replies
121
Views
34K
Anonymous
Replies
2
Views
3K
Anonymous
Replies
8
Views
5K
Anonymous
Replies
29
Views
10K
Anonymous
Replies
13
Views
4K
Anonymous
Replies
42
Views
13K
Anonymous
Replies
3
Views
3K
Anonymous
Replies
7
Views
4K
Anonymous
Replies
16
Views
9K
Anonymous